These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31872796)

  • 1. Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient.
    Vechi HT; Sousa ASV; Cunha MAD; Shaw JJ; Luz KG
    Am J Trop Med Hyg; 2020 Feb; 102(2):268-273. PubMed ID: 31872796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
    Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
    Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
    AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.
    Neves LO; Talhari AC; Gadelha EP; Silva Júnior RM; Guerra JA; Ferreira LC; Talhari S
    An Bras Dermatol; 2011; 86(6):1092-101. PubMed ID: 22281895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN; Croft SL
    Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of leishmaniasis in India.
    Thakur CP
    Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
    Minodier P; Retornaz K; Horelt A; Garnier JM
    Fundam Clin Pharmacol; 2003 Apr; 17(2):183-8. PubMed ID: 12667228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
    Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
    Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Coinfection by
    Corrêa Soares GH; Silva ABSD; Ferreira LSS; Ithamar JS; Medeiros GA; Pereira SRF; Lima MIS; E Silva de Azevedo CMP
    Am J Trop Med Hyg; 2020 Sep; 103(3):1076-1080. PubMed ID: 32394886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].
    Colomba C; Scarlata F; Salsa L; Frasca Polara V; Titone L
    Infez Med; 2004 Jun; 12(2):139-43. PubMed ID: 15316302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis complicating idiopathic CD4+ T-cell lymphocytopenia: 2 case reports.
    Fox-Lewis A; Lockwood DNJ
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005412. PubMed ID: 28493863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of clinical and laboratory findings of adult visceral leishmaniasis cases].
    Ural S; Kaptan F; Sezak N; El S; Örmen B; Türker N; Demirdal T; Vardar İ; Özkan Çayıröz P; Çakalağaoğlu F
    Mikrobiyol Bul; 2015 Oct; 49(4):586-93. PubMed ID: 26649416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
    Gradoni L; Gramiccia M; Scalone A
    Parassitologia; 2004 Jun; 46(1-2):199-201. PubMed ID: 15305716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
    Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
    Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
    Mishra M
    J Assoc Physicians India; 1995 Apr; 43(4):306. PubMed ID: 8713286
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
    Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.